- Mechanism
- Modulates gene expression and reduces oxidative stress
- Typical research dose
- 1-10 mg/day (subcutaneous or oral)
- Route
- subcutaneous, oral
- Half-life
- Minutes (plasma), months (cellular effect)
- Legal status
- Research Only
Overview
Pinealon is a synthetic tripeptide bioregulator originally developed by the Khavinson Institute to target the central nervous system and brain tissue. It functions by interacting directly with cellular DNA to promote the repair and regeneration of neurons, potentially mitigating the effects of oxidative stress and aging. Researchers study the Pinealon peptide for its promising applications in neuroprotection, cognitive enhancement, and the regulation of circadian rhythms.
Potential Benefits
- Neuroprotection: Research indicates the Pinealon peptide may protect brain cells from oxidative stress and hypoxia by stimulating cellular repair mechanisms and reducing apoptosis (Khavinson et al., 2012).
- Cognitive Enhancement: Animal studies suggest this bioregulator improves memory, focus, and learning capacity by promoting neurogenesis and synaptic plasticity in the central nervous system.
- Sleep Regulation: Pinealon is investigated for its ability to normalize circadian rhythms and improve sleep quality by modulating pineal gland function and melatonin pathways.
- Anti-Aging Properties: By interacting with DNA to regulate gene expression, this peptide may slow cellular senescence and preserve functional capacity in aging brain tissues.
- Mood Stabilization: Preliminary evidence points to potential benefits in reducing symptoms of depression and anxiety through the balancing of neurotransmitter levels and reduction of neuroinflammation.
Side Effects
Common side effects:
- Mild irritation or redness at the subcutaneous injection site
- Temporary headaches during initial administration
- Slight fatigue or drowsiness, particularly if taken during the day
- Mild gastrointestinal discomfort when administered orally
Rare or serious side effects:
- Allergic reactions to the peptide sequence or synthesis byproducts
- Unintended shifts in circadian rhythms if dosed incorrectly
- Overstimulation leading to temporary insomnia
Pinealon is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.
Mechanism of Action
Gene expression modulation is the primary mechanism by which the Pinealon peptide exerts its neuroprotective effects. As a short-chain bioregulator, it penetrates the cell membrane and nuclear envelope to interact directly with specific DNA sequences. This interaction stimulates the transcription of proteins essential for neuronal repair, survival, and synaptic plasticity.
Antioxidant pathway activation represents another crucial function of this synthetic tripeptide. By upregulating the production of endogenous antioxidants, Pinealon helps neutralize reactive oxygen species (ROS) in brain tissue. This reduction in oxidative stress prevents cellular apoptosis and preserves cognitive function under conditions of hypoxia or age-related decline.
Origin & History
The Khavinson Institute in Russia first synthesized Pinealon as part of a broader initiative to develop short-chain peptide bioregulators for military personnel and aging populations. Professor Vladimir Khavinson and his team designed this specific tripeptide to mimic the biological activity of naturally occurring peptides found in the brain and pineal gland.
Regulatory status for Pinealon remains strictly limited to research and experimental applications in most global jurisdictions. While it is widely studied in Eastern Europe as a dietary supplement or geroprotector, the FDA and EMA have not approved the Pinealon peptide for medical use, keeping it classified as a research-only chemical.